Capsular Repair in FAI Impingement Surgery

November 29, 2017 updated by: University of Colorado, Denver

The Efficacy of Capsular Repair in Arthroscopic Femoroacetabular

The Investigator's hypothesis is that capsular repair (after CAM or mixed Femoroacetabular Impingement (FAI) surgery) requiring moderate capsulotomy, would result in similar patient outcomes in the short, mid and long term, both clinically and radiographically, compared to those without capsular repair. The objective of this clinical trial is to evaluate the clinical efficacy with regards to pain, range of motion and return to work and activities of daily living. Secondary objective is to evaluate radiographic characteristics between both groups.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

23

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 51 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Male or female patients aged between 16-51 years of age.
  2. Healthy patients undergoing hip arthroscopy due to Cam or mixed FAI
  3. No major osteoarthritic (OA) changes according to X-Ray and surgery observation (Tonnis 0-1)
  4. No previous hip surgery
  5. No other influential disabilities in lower limbs
  6. No chronic use of NSAID, analgesics, steroids or chemotherapy drugs
  7. Base line activity level (Tegner 3 and above)

Exclusion Criteria:

  1. Patients with concomitant disease that may affect joints
  2. Patients with major ligamentous laxity
  3. Patients who have undergone only minor vertical capsulotomy (as in small pincer only lesions)
  4. Patients with extreme range of motion needs (such as ballet dancers)
  5. Patients suffering from connective tissue disease
  6. Patients suffering from bilateral symptomatic FAI that are being operated on for their first hip
  7. Patients with relative or proven dysplastic hip determined by center edge angle and/or extreme version abnormalities as measured on apical CT/MR cuts and pelvic XR
  8. Patients who needed Ilio-Psoas release
  9. Patients whose cartilage hip status was defined as advanced OA during surgery
  10. Patients who following surgery would be instructed to avoid full weight bearing on the operated hip for more than 4 weeks
  11. Concomitant use of PRP (platelet rich plasma) or hyaluronic acid during the surgical procedure
  12. Patients with preoperative hip stiffness

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Capsular Repair
Capsular Repair arm. The first hip is randomized, opposite treatment on second hip. One Hip will receive the capsular repair while the other hip will not.
Placebo Comparator: No Capsular Repair
Placebo arm. One hip is randomized to capsular repair while the other hip has no capsular repair.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in iHOT Version 12
Time Frame: Baseline, 6weeks, 12weeks, 6months, 1Year, 2Years
Baseline, 6weeks, 12weeks, 6months, 1Year, 2Years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Marx activity score
Time Frame: Baseline, 6weeks, 12weeks, 6months, 1Year, 2Years
Baseline, 6weeks, 12weeks, 6months, 1Year, 2Years
Change in Range of Motion
Time Frame: Baseline, 14days, 6weeks, 12weeks, 6months, 1Year, 2Years
Baseline, 14days, 6weeks, 12weeks, 6months, 1Year, 2Years
Change in X-rays
Time Frame: 6weeks, 6months, 1Year
XR will be used for initial evaluation and for post op resection assessment and long-term OA changes. X-rays will be done post-operatively at 6 weeks, 6 months and 1 year time-frames. All these x-rays are normally performed as standard of care.
6weeks, 6months, 1Year
Change in MRI
Time Frame: 6weeks, 6months
MRI will be conducted at 6 weeks and 6 months post op to evaluate capsular healing status (primary radiological outcome measure), intra articular adhesions, extra articular scarring, labrum/cartilage status and resection assessment. This MRI will be paid by department funds.
6weeks, 6months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2014

Primary Completion (Actual)

October 1, 2017

Study Completion (Actual)

October 1, 2017

Study Registration Dates

First Submitted

December 5, 2016

First Submitted That Met QC Criteria

December 8, 2016

First Posted (Estimate)

December 13, 2016

Study Record Updates

Last Update Posted (Actual)

December 2, 2017

Last Update Submitted That Met QC Criteria

November 29, 2017

Last Verified

November 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 13-2310

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe